Arcadia Biosciences Inc (RKDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 2,599 | -7,038 | -2,974 | -1,362 | -2,423 |
| Depreciation Amortization | 48 | 608 | 504 | 408 | 228 |
| Accounts receivable | -193 | -762 | -445 | -334 | -246 |
| Other Working Capital | -701 | -1,446 | -975 | -736 | -598 |
| Other Operating Activity | -3,341 | -989 | -3,528 | -3,642 | -171 |
| Operating Cash Flow | $-1,588 | $-9,627 | $-7,418 | $-5,666 | $-3,210 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | 318 | 326 | 146 | 4 |
| Net Acquisitions | N/A | -2,000 | 2,000 | 2,000 | N/A |
| Sale Of Investment | N/A | 5,024 | 2,501 | 2,501 | N/A |
| Purchase Sale Intangibles | 500 | 4,000 | N/A | N/A | N/A |
| Other Investing Activity | 500 | 4,000 | 0 | 0 | 0 |
| Investing Cash Flow | $500 | $7,342 | $4,827 | $4,647 | $4 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 5 | 9 | 9 | 5 | 5 |
| Financing Cash Flow | $5 | $9 | $9 | $5 | $5 |
| Beginning Cash Position | 4,242 | 6,518 | 6,518 | 6,518 | 6,518 |
| End Cash Position | 3,159 | 4,242 | 3,936 | 5,504 | 3,317 |
| Net Cash Flow | $-1,083 | $-2,276 | $-2,582 | $-1,014 | $-3,201 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,588 | -9,627 | -7,418 | -5,666 | -3,210 |
| Capital Expenditure | N/A | -16 | -16 | -16 | -13 |
| Free Cash Flow | -1,588 | -9,643 | -7,434 | -5,682 | -3,223 |